Close

Anti-DLL4 Therapeutic Antibody (TAB-744)

DESCRIPTION CATALOG # SIZE PRICE
Anti-DLL4 Therapeutic Antibody TAB-744 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant human monoclonal antibody expressed in CHO binding to human DLL4. Anti-DLL4 Therapeutic Antibody is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.
  • Target
  • DLL4
  • Type
  • IgG1 - kappa
  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, IHC and most other immunological methods.
  • CAS
  • 1192578-27-0
  • Predicted N terminal
  • QVQLVESG
  • Molecular Weight
  • Approximately 150 kDa
  • Purity
  • >95.0% as determined by analysis by RP-HPLC.
  • Size
  • 1mg
  • Storage
  • At -20°C for one year.

BACKGROUND

  • Introduction
  • Anti-DLL4 Therapeutic Antibody is a human monoclonal antibody that binds to DLL4. It acts as an immunomodulator.
  • Antigen Description
  • This gene is a homolog of the Drosophila delta gene. The delta gene family encodes Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain.
  • Function
  • Notch binding; calcium ion binding;
  • Synonyms
  • DLL4; delta-like 4 (Drosophila); delta like 4 homolog (Drosophila); delta-like protein 4; delta4; delta 4; delta ligand 4; notch ligand DLL4; delta-like 4 homolog; delta-like 4 protein; notch ligand delta-2; drosophila Delta homolog 4; hdelta2; MGC126344;

Related Products

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us